Clinical Trials Logo

Hypotension and Shock clinical trials

View clinical trials related to Hypotension and Shock.

Filter by:

NCT ID: NCT03927066 Completed - Clinical trials for Hypotension and Shock

Physiological Validation of Current Machine Learning Models for Hemodynamic Instability in Humans

Start date: May 12, 2021
Phase: N/A
Study type: Interventional

This study will be collecting data on participants undergoing lower body negative pressure (LBNP) to simulate progressive blood loss. The goal of the study is to collect data to allow for development of an algorithm with machine learning to predict blood pressure responses to hyporvolemia by analyzing the arterial waveforms collected during LBNP.

NCT ID: NCT03701646 Completed - Shock Clinical Trials

ClearSight Validation in Pediatrics

Start date: November 2, 2017
Phase:
Study type: Observational

Specific aim 1: The specific aim of this study is to compare cardiac output measurements as well as cardiac index, and stroke volume obtained via thermodilution during a cardiac catheterization with data obtained by the ClearSight cardiac output monitoring system. Specific aim 2: To compare arterial blood pressure measurements obtained by arterial line with arterial waveform measurements obtained by the ClearSight System. The hypothesis is: Cardiac output measurements or arterial blood pressure measurements taken non-invasively with the ClearSight system in pediatric patients who are either undergoing cardiac catheterization or have an arterial line will correlate with cardiac output measurements taken by pulmonary artery catheter thermodilution or arterial pressures measured by an arterial line.

NCT ID: NCT03671070 Not yet recruiting - Clinical trials for Hypotension and Shock

Role of Low Dose Epinephrine Boluses In Acute Hypotension

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

The Study evaluates the role of low dose epinephrine boluses in management of acute hypo-tension VS The Traditional management of acute hypo-tension. Half of the participants suffering from acute hypo-tension will receive low dose epinephrine boluses (≤ 5 µg/kg/dose) and the other half will receive traditional management of shock

NCT ID: NCT03582501 Completed - Clinical trials for Hypotension and Shock

Measurement of Hemodynamic Responses to Lower Body Negative Pressure

LBNP
Start date: January 8, 2019
Phase: N/A
Study type: Interventional

This study will be collecting data on participants undergoing lower body negative pressure (LBNP) to simulate progressive blood loss. The goal of the study is to collect data to allow for development of an algorithm with machine learning to predict blood pressure responses to hypovolemia by analyzing the arterial waveforms collected during LBNP.

NCT ID: NCT03407287 Terminated - Atrial Fibrillation Clinical Trials

Peripheral Venous Analysis (PIVA) for Predicting Volume Responsiveness and Fluid Status

PIVA
Start date: January 8, 2018
Phase:
Study type: Observational

The aim of this study is to determine the effects of fluid alternations, hemodynamic changes, mechanical ventilation, pharmacologic agents, positional changes, and comorbidities on the Peripheral Intravenous waveform Analysis (PIVA) signal.

NCT ID: NCT03214809 Terminated - Dyspnea Clinical Trials

The Use of a Point-of-care Thoracic Ultrasound Protocol for Hospital Medical Emergency Teams

METUS
Start date: January 18, 2019
Phase: N/A
Study type: Interventional

Study to assess the possible effects of the use of a point-of-care thoracic ultrasound protocol for hospital medical emergency teams (MET)

NCT ID: NCT02782819 Recruiting - Clinical trials for Hypotension and Shock

A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation

Start date: September 2014
Phase: N/A
Study type: Interventional

Fluid resuscitation is the most effective treatment of shock. Isotonic crystalloid solution is the current recommended initial fluid resuscitation. However, this kind of fluid has high volume of distribution and may require large volume administration before achieve therapeutic goal of shock reversal. There are rising concern about the delay in shock reversal and adverse consequences of large amount volume of fluid therapy. Colloid fluid have been used as the alternate fluid resuscitation, aiming to limit the volume of fluid resuscitation and promote shock reversal. Whether colloid infusion can improve shock reversal rate and decrease complication associated with fluid resuscitation, had inconclusive information.

NCT ID: NCT02070276 Completed - Clinical trials for Hypotension and Shock

Predict Fluid Responsiveness in Spinal Anesthesia

CERU-1401
Start date: May 2014
Phase: N/A
Study type: Interventional

Spinal anesthesia is still the regional anesthesia technique most widely employed in everyday clinical practice. The most feared and common of its well known side effects consist in an abrupt reduction of systemic vascular resistances, with consequence risk of systemic hypotension. To prevent this potentially severe complication, an adequate correction of patients' volume status through a preventive administration of fluids is widely used. However this volume repletion is commonly accomplished on an empirical basis, without having a real insight of patient hemodynamic status, carrying the risk of possible volume overload. Aim of the study is to test the clinical impact of two simple, non-invasive methods to guide volemic repletion before spinal anesthesia on the reduction of significant hypotension rate, compared to empirical fluid administration.